1. India Stocks

  2. •

    Consumer non-durables

  3. •

    Household/Personal care
Procter & Gamble Hygiene & Health Care Ltd.

Procter & Gamble Hygiene & Health Care Ltd.

6,806.30
INR
+2.10
(+0.03%)
243.59EPS
36.59P/E
289.34BMarket Cap
Nov 05Next Earn
Procter & Gamble Hygiene & Health Care Ltd.
BSE:PGHH
(Bombay Stock Exchange)

Recent

price

6,806.30

P/E

ratio

36.59

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2026
TTM
INR
278.63
308.95
398.85
519.05
630.67
718.49
700.15
714.65
756.37
906.47
923.74
1,099.86
1,168.32
1,203.06
1,291.27
1,319.01
1,305.05
Revenue per Share
55.38
46.48
55.85
62.6
93.04
106.63
130.16
133.31
115.4
129.12
133.42
200.79
177.37
208.91
207.95
263.86
243.59
Basic EPS, GAAP
53.26
19.42
38.68
32.1
103.26
131.1
92.36
123.57
116.25
122.26
130.23
256.16
161.21
240.7
131.19
269.41
- -
Free Cash Flow per Basic Share
22.5
22.5
22.5
22.5
25
27.5
36.41
479.03
32.49
96.45
57.87
340
175
145
265
260
- -
Dividend per Share
164.7
185.03
214.73
248.09
308.96
414.57
508.85
162.08
248.15
280.05
356.7
220.04
227.22
291.44
238.71
232.12
- -
Book Value per Share
164.7
185.03
214.73
248.09
308.96
414.57
508.85
162.08
248.15
280.05
356.7
220.04
227.22
291.44
238.71
232.12
- -
Tangible Book Value per Share
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
32
Basic Weighted Avg Shares
9,045
10,029
12,947
16,849
20,472
23,323
22,727
23,198
24,552
29,425
29,985
35,702
37,925
39,052
41,916
42,816
42,364
Sales/Revenue/Turnover
26.04
17.63
14.51
13.98
19.67
19.34
24.94
26.68
24.2
19.57
19.84
24.03
20.95
21.11
22.64
27.01
24.48
Operating Margin (%)
250
222
281
313
352
525
517
597
524
498
479
477
529
584
565
374
379
Depreciation Expense
1,798
1,509
1,813
2,032
3,020
3,461
4,225
4,327
3,746
4,191
4,331
6,518
5,758
6,781
6,750
8,565
7,907
Net Income, GAAP
23.05
14.63
18.71
28.99
34.39
30.88
33.52
35.58
35.61
30.99
27.07
25.07
27.13
19.22
28.13
26.58
26.21
Effective Tax Rate (%)
19.88
15.04
14
12.06
14.75
14.84
18.59
18.65
15.26
14.24
14.44
18.26
15.18
17.37
16.1
20
18.67
Profit Margin (%)
3,400
3,226
3,704
3,995
5,103
7,569
11,208
208
2,649
4,476
7,333
2,819
2,755
4,107
2,190
2,087
- -
Working Capital
- -
4
4
- -
- -
- -
- -
- -
- -
- -
15
2
19
8
- -
- -
- -
LT Debt
5,346
6,006
6,970
8,053
10,029
13,457
16,518
5,261
8,055
9,091
11,579
7,143
7,376
9,460
7,749
7,535
- -
Total Equity
37.09
26.29
22.06
19.33
25.34
21.26
20.9
30.17
44.71
40.79
38.52
64.35
74.27
72.94
70.14
100.91
- -
Return on Invested Capital (%)
36.89
26.58
27.79
26.89
33.75
29.79
28.43
40.28
56.6
49.21
42.19
69.8
79.96
81.21
80.37
112.7
- -
Return on Capital (%)
36.89
26.58
27.94
27.05
33.41
29.48
28.19
39.74
56.26
48.89
41.91
69.63
79.31
80.56
78.45
112.08
- -
Return on Common Equity (%)

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
9
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
32
32
32
Market Capitalization
419,998
302,696
289,339

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
11,440
- -
Cash, Cash Equivalents & STI
- -
5,570
- -
Accounts Receivable, Net
- -
2,428
- -
Inventories
- -
2,179
- -
Total Current Liabilities
- -
9,352
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
9
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
2.03%
-5.53%
-2.76%
Free Cash Flow
17.88%
33.76%
105.36%
Net Income, GAAP
10.93%
16.61%
26.89%
Sales/Revenue/Turnover
6.49%
7.55%
2.15%
Total Cash Common Dividend
181.45%
100.55%
-1.89%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2026
9,352
11,489
12,599
9,377
42,816
2027
8,899
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2026
59.17
64.65
92.87
47.17
263.86
2027
38.9
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2026
- -
- -
- -
- -
260
2027
- -
- -
- -
- -
- -
Similar Companies
Procter & Gamble Company (The) (NYSE:PG)
Cupid Limited (NSE:CUPID)
Hindustan Unilever Limited (NSE:HINDUNILVR)
Colgate-Palmolive (India) Limited (NSE:COLPAL)
Dabur India Limited (NSE:DABUR)
e.l.f. Beauty, Inc. (NYSE:ELF)
Business
Procter & Gamble Hygiene and Health Care Limited manufactures and sells branded packaged fast-moving consumer goods (FMCG) primarily in the feminine hygiene and healthcare segments. Its core products include sanitary napkins under the Whisper brand; baby care products; health care items such as Vicks cough and cold remedies, Vicks Vaporub, and Pepto-Bismol; and personal hygiene products including soaps and sanitizers. The company operates primarily in India with a pan-India presence through manufacturing facilities in Goa and a distribution network covering 28 states and 8 union territories, while also exporting products to 12 international markets. Incorporated in 1964 and headquartered in Mumbai, it functions as a subsidiary of Procter & Gamble, a global FMCG leader. Major recent developments include the launch of Whisper Ultra sanitary pads featuring Curvewear Technology for enhanced comfort and leak protection, an upgraded Vicks Vaporub formula, the launch of Vicks cough syrup exclusively on e-commerce, and continuation of strategic co-created consumer communication partnerships, such as with Zepto, to boost online engagement. The company remains a market leader in both feminine care (almost half the market share) and cough and cold categories (over half the market), while focusing on innovation-driven category growth and expanding its ecommerce presence. It also recently announced management changes, reflecting its ongoing strategic evolution and commitment to integrated growth. Procter & Gamble Hygiene and Health Care Limited reported a revenue increase driven by innovations in the feminine hygiene category and maintains a strong emphasis on consumer-centric product development and market expansion.